Stratified Medicine Pipeline
Cellworks’s cumulative biology knowledge from extensive modeling and bio-simulation of molecular interactions in personalized medicine is the basis of Cellworks’s drug discovery platform. When therapies we have discovered in personalized medicine are applicable to a broad stratified population segment, we choose to create new chemical entities (NCE).
These NCE’s are then validated through a traditional FDA clinical trial pipeline. Each of these NCE’s has a companion diagnostic which determines when the drug can be administered to a patient. We currently have over a dozen drug assets at various stages of clinical validation, several of which are available for licensing.